instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Status epilepticus'. | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | ATROPINE | DrugsGivenReaction | CC BY | 33912057 | 19,685,657 | 2021 |
What was the administration route of drug 'ATROPINE'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | Oral | DrugAdministrationRoute | CC BY | 33912057 | 19,685,657 | 2021 |
What was the dosage of drug 'ATROPINE'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | INGESTED 35 TABLETS EACH CONTAINING 2.5 MG DIPHENOXYLATE AND 0.025 MG ATROPINE | DrugDosageText | CC BY | 33912057 | 19,685,657 | 2021 |
What was the outcome of reaction 'Accidental overdose'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | Recovered | ReactionOutcome | CC BY | 33912057 | 19,685,657 | 2021 |
What was the outcome of reaction 'Encephalopathy'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | Recovered | ReactionOutcome | CC BY | 33912057 | 19,685,657 | 2021 |
What was the outcome of reaction 'Focal dyscognitive seizures'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | Recovered | ReactionOutcome | CC BY | 33912057 | 19,685,657 | 2021 |
What was the outcome of reaction 'Generalised tonic-clonic seizure'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | Recovered | ReactionOutcome | CC BY | 33912057 | 19,685,657 | 2021 |
What was the outcome of reaction 'Respiratory arrest'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | Recovered | ReactionOutcome | CC BY | 33912057 | 19,685,657 | 2021 |
What was the outcome of reaction 'Status epilepticus'? | Case Report: Multiple Seizures After a Diphenoxylate-Atropine Overdose in a Small Child.
Poisoning is a type of accidental injury and it is considered a major public health problem worldwide. Oral drug poisoning in children is an important cause of accidental injury and even death. It is a common critical emergency in ... | Recovered | ReactionOutcome | CC BY | 33912057 | 19,685,657 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33912125 | 20,211,520 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | LEVETIRACETAM, OXCARBAZEPINE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33912125 | 20,212,907 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Multiple-drug resistance'. | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | IMMUNE GLOBULIN NOS, LEVETIRACETAM, METHYLPREDNISOLONE, OXCARBAZEPINE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33912125 | 20,222,335 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33912125 | 20,211,520 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Partial seizures'. | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | IMMUNE GLOBULIN NOS, LEVETIRACETAM, METHYLPREDNISOLONE, OXCARBAZEPINE, TOPIRAMATE | DrugsGivenReaction | CC BY | 33912125 | 20,222,335 | 2021 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33912125 | 20,211,520 | 2021 |
What was the dosage of drug 'IMMUNE GLOBULIN NOS'? | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | 2 G/KG | DrugDosageText | CC BY | 33912125 | 20,222,335 | 2021 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | 20 MG/KG/DAY FOR 3 DAYS | DrugDosageText | CC BY | 33912125 | 20,222,335 | 2021 |
What was the dosage of drug 'RITUXIMAB'? | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | 375 MILLIGRAM/SQ. METER, 4 TIMES; RECEIVED 1 CYCLE | DrugDosageText | CC BY | 33912125 | 20,211,520 | 2021 |
What was the outcome of reaction 'Partial seizures'? | Case Report: Autoimmune Encephalitis Associated With Anti-glutamic Acid Decarboxylase Antibodies: A Pediatric Case Series.
Background: Antibodies against glutamic acid decarboxylase (GAD) are associated with various neurologic conditions described in patients, including stiff person syndrome, cerebellar ataxia, refract... | Recovering | ReactionOutcome | CC BY | 33912125 | 20,222,335 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malig... | ACENOCOUMAROL, ASPIRIN, DARATUMUMAB, HEPARIN SODIUM, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33912194 | 19,980,141 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malig... | ACENOCOUMAROL, ASPIRIN, DARATUMUMAB, HEPARIN SODIUM, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33912194 | 19,951,466 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malig... | ACENOCOUMAROL, ASPIRIN, DARATUMUMAB, HEPARIN SODIUM, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33912194 | 19,980,141 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Upper respiratory tract infection'. | Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malig... | ACENOCOUMAROL, ASPIRIN, DARATUMUMAB, HEPARIN SODIUM, HYDROXYCHLOROQUINE | DrugsGivenReaction | CC BY | 33912194 | 19,980,141 | 2021 |
What was the administration route of drug 'DARATUMUMAB'? | Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malig... | Other | DrugAdministrationRoute | CC BY | 33912194 | 19,980,141 | 2021 |
What was the administration route of drug 'HEPARIN SODIUM'? | Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malig... | Parenteral | DrugAdministrationRoute | CC BY | 33912194 | 19,980,141 | 2021 |
What was the dosage of drug 'DARATUMUMAB'? | Case Report: Resetting the Humoral Immune Response by Targeting Plasma Cells With Daratumumab in Anti-Phospholipid Syndrome.
Monoclonal antibodies (mAb) targeting plasma cells are malignant gammopathy designed and approved therapies. In recent years, these antibodies have also been increasingly introduced for non-malig... | 8 MILLIGRAM/KILOGRAM | DrugDosageText | CC BY | 33912194 | 19,951,466 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pancytopenia'. | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE SODIUM, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY | 33912231 | 19,463,264 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Septic shock'. | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | CYCLOPHOSPHAMIDE, CYTARABINE, DEXAMETHASONE, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE SODIUM, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY | 33912231 | 19,463,264 | 2021 |
What was the dosage of drug 'CYCLOPHOSPHAMIDE'? | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | UNK, CYCLIC | DrugDosageText | CC BY | 33912231 | 19,463,264 | 2021 |
What was the dosage of drug 'CYTARABINE'? | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | UNK, CYCLIC | DrugDosageText | CC BY | 33912231 | 19,463,264 | 2021 |
What was the dosage of drug 'DEXAMETHASONE'? | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | UNK, CYCLIC | DrugDosageText | CC BY | 33912231 | 19,463,264 | 2021 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | UNK, CYCLIC | DrugDosageText | CC BY | 33912231 | 19,463,264 | 2021 |
What was the dosage of drug 'METHOTREXATE SODIUM'? | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | UNK, CYCLIC | DrugDosageText | CC BY | 33912231 | 19,463,264 | 2021 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | UNK, CYCLIC | DrugDosageText | CC BY | 33912231 | 19,463,264 | 2021 |
What was the outcome of reaction 'Septic shock'? | Comparison in safety of chemotherapy protocols for blood cancers: toxicity of H-CVAD versus GELA/BURKIMAB/PETHEMA LAL.
The Hyper-CVAD/Methotrexate-Cytarabine (H-CVAD/MTX-AraC) chemotherapy protocol has been one of the standard treatments for blood cancers, such as Mantle cell lymphoma (MCL), Burkitt's lymphoma (BL) and... | Fatal | ReactionOutcome | CC BY | 33912231 | 19,463,264 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rheumatoid arthritis'. | Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis.
Immune checkpoint inhibitors (ICIs) improved cancer therapy by inducing a higher immune system activity. This effect can cause rheumatic immune-relate... | PEMBROLIZUMAB | DrugsGivenReaction | CC BY-NC | 33912248 | 19,213,867 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cutaneous mucormycosis'. | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | APIXABAN, IBRUTINIB, METOPROLOL TARTRATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33912391 | 19,819,343 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | AMPHOTERICIN B, APIXABAN, CEFEPIME HYDROCHLORIDE, CEPHALEXIN, IBRUTINIB, METOPROLOL TARTRATE, POSACONAZOLE, PREDNISONE, SULFADIAZINE | DrugsGivenReaction | CC BY-NC-ND | 33912391 | 19,369,146 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pseudomonas infection'. | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | APIXABAN, IBRUTINIB, METOPROLOL TARTRATE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33912391 | 19,819,343 | 2021 |
What was the administration route of drug 'IBRUTINIB'? | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33912391 | 19,369,146 | 2021 |
What was the administration route of drug 'PREDNISOLONE'? | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33912391 | 19,819,343 | 2021 |
What was the administration route of drug 'PREDNISONE'? | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33912391 | 19,369,146 | 2021 |
What was the administration route of drug 'SULFADIAZINE'? | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | Topical | DrugAdministrationRoute | CC BY-NC-ND | 33912391 | 19,369,146 | 2021 |
What was the outcome of reaction 'Cutaneous mucormycosis'? | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | Recovered | ReactionOutcome | CC BY-NC-ND | 33912391 | 19,819,343 | 2021 |
What was the outcome of reaction 'Pseudomonas infection'? | Cutaneous mucormycosis in a chronic lymphocytic leukemia patient on ibrutinib.
Mucorales is a zygomycete fungi known to cause opportunistic infections in immunosuppressed hosts. Spores may be inhaled, causing rhinocerebral or pulmonary infections, or gastrointestinal infections if swallowed. Less often, cutaneous mucor... | Recovered | ReactionOutcome | CC BY-NC-ND | 33912391 | 19,819,343 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, GRANULOCYTE COLONY-STIMULATING FACTOR NOS, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33912468 | 19,964,733 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiomyopathy'. | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | CYCLOPHOSPHAMIDE, DOXORUBICIN, FILGRASTIM, PREDNISONE, RITUXIMAB, VINCRISTINE | DrugsGivenReaction | CC BY | 33912468 | 19,903,552 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Polyneuropathy'. | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | FLUOROURACIL, LEUCOVORIN, OXALIPLATIN | DrugsGivenReaction | CC BY | 33912468 | 20,033,994 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE, VINCRISTINE | DrugsGivenReaction | CC BY | 33912468 | 20,060,378 | 2021 |
What was the dosage of drug 'DOXORUBICIN HYDROCHLORIDE'? | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | 50 MG/M2, CYCLIC | DrugDosageText | CC BY | 33912468 | 19,964,733 | 2021 |
What was the dosage of drug 'FLUOROURACIL'? | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | RECEIVED CHEMOTHERAPY WITH FOLFOX4 REGIMEN COMPRISING OF.. | DrugDosageText | CC BY | 33912468 | 20,033,994 | 2021 |
What was the dosage of drug 'LEUCOVORIN'? | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | RECEIVED CHEMOTHERAPY WITH FOLFOX4 REGIMEN COMPRISING OF F.. | DrugDosageText | CC BY | 33912468 | 20,033,994 | 2021 |
What was the outcome of reaction 'Aortic valve incompetence'? | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | Recovering | ReactionOutcome | CC BY | 33912468 | 19,964,733 | 2021 |
What was the outcome of reaction 'Cardiac failure'? | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | Recovering | ReactionOutcome | CC BY | 33912468 | 19,964,733 | 2021 |
What was the outcome of reaction 'Tachycardia'? | Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature.
COVID-19 has become the biggest public health problem and one of the most important causes of death in many countries in the world. SARS-CoV-2 infection is most likely to be fatal in elderly patients with concomitant diseases. I... | Recovering | ReactionOutcome | CC BY | 33912468 | 19,964,733 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Induction with four cycles of platinum-based chemotherapy was the standard of care for metastatic non-small cell lung cancer (NSCLC) until the approval of immune checkpoint blockade (... | PACLITAXEL, PEMBROLIZUMAB | DrugsGivenReaction | CC BY | 33912470 | 19,268,038 | 2021 |
What was the administration route of drug 'PACLITAXEL'? | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Induction with four cycles of platinum-based chemotherapy was the standard of care for metastatic non-small cell lung cancer (NSCLC) until the approval of immune checkpoint blockade (... | Intravenous drip | DrugAdministrationRoute | CC BY | 33912470 | 19,268,038 | 2021 |
What was the dosage of drug 'PACLITAXEL'? | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Induction with four cycles of platinum-based chemotherapy was the standard of care for metastatic non-small cell lung cancer (NSCLC) until the approval of immune checkpoint blockade (... | 100 MILLIGRAM/SQ. METER | DrugDosageText | CC BY | 33912470 | 19,268,038 | 2021 |
What was the dosage of drug 'PEMBROLIZUMAB'? | Consolidation With Pembrolizumab and Nab-Paclitaxel After Induction Platinum-Based Chemotherapy for Advanced Non-Small Cell Lung Cancer.
Induction with four cycles of platinum-based chemotherapy was the standard of care for metastatic non-small cell lung cancer (NSCLC) until the approval of immune checkpoint blockade (... | 200 MILLIGRAM | DrugDosageText | CC BY | 33912470 | 19,268,038 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Brain-responsive neurostimulation in adult-onset rasmussen's encephalitis.
Epilepsy associated with Rasmussen's encephalitis (RE) is highly resistant to standard therapy and continues to present a therapeutic challenge. While epilepsy surgery remains the most effective management for patients with drug-resistant focal ... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33912823 | 20,315,764 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Brain-responsive neurostimulation in adult-onset rasmussen's encephalitis.
Epilepsy associated with Rasmussen's encephalitis (RE) is highly resistant to standard therapy and continues to present a therapeutic challenge. While epilepsy surgery remains the most effective management for patients with drug-resistant focal ... | RITUXIMAB | DrugsGivenReaction | CC BY-NC-ND | 33912823 | 20,315,764 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Bronchopulmonary aspergillosis'. | Retinal manifestations in patients following COVID-19 infection: A consecutive case series.
To describe retinal manifestations seen in patients associated with COVID-19 infection at a multi-specialty tertiary care hospital in Southern India.
In this retrospective chart review, all consecutive cases presenting to the Re... | AMOXICILLIN\CLAVULANATE POTASSIUM, INSULIN NOS, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-SA | 33913876 | 19,548,883 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'COVID-19'. | Retinal manifestations in patients following COVID-19 infection: A consecutive case series.
To describe retinal manifestations seen in patients associated with COVID-19 infection at a multi-specialty tertiary care hospital in Southern India.
In this retrospective chart review, all consecutive cases presenting to the Re... | AMOXICILLIN\CLAVULANATE POTASSIUM, INSULIN NOS, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-SA | 33913876 | 19,548,883 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Visual impairment'. | Retinal manifestations in patients following COVID-19 infection: A consecutive case series.
To describe retinal manifestations seen in patients associated with COVID-19 infection at a multi-specialty tertiary care hospital in Southern India.
In this retrospective chart review, all consecutive cases presenting to the Re... | AMOXICILLIN\CLAVULANATE POTASSIUM, INSULIN NOS, MYCOPHENOLATE MOFETIL, PREDNISOLONE, TACROLIMUS, VORICONAZOLE | DrugsGivenReaction | CC BY-NC-SA | 33913876 | 19,548,883 | 2021-05 |
What was the administration route of drug 'INSULIN NOS'? | Retinal manifestations in patients following COVID-19 infection: A consecutive case series.
To describe retinal manifestations seen in patients associated with COVID-19 infection at a multi-specialty tertiary care hospital in Southern India.
In this retrospective chart review, all consecutive cases presenting to the Re... | Subcutaneous | DrugAdministrationRoute | CC BY-NC-SA | 33913876 | 19,548,883 | 2021-05 |
What was the administration route of drug 'MYCOPHENOLATE MOFETIL'? | Retinal manifestations in patients following COVID-19 infection: A consecutive case series.
To describe retinal manifestations seen in patients associated with COVID-19 infection at a multi-specialty tertiary care hospital in Southern India.
In this retrospective chart review, all consecutive cases presenting to the Re... | Oral | DrugAdministrationRoute | CC BY-NC-SA | 33913876 | 19,548,883 | 2021-05 |
What was the administration route of drug 'PREDNISOLONE'? | Retinal manifestations in patients following COVID-19 infection: A consecutive case series.
To describe retinal manifestations seen in patients associated with COVID-19 infection at a multi-specialty tertiary care hospital in Southern India.
In this retrospective chart review, all consecutive cases presenting to the Re... | Oral | DrugAdministrationRoute | CC BY-NC-SA | 33913876 | 19,548,883 | 2021-05 |
What was the administration route of drug 'VORICONAZOLE'? | Retinal manifestations in patients following COVID-19 infection: A consecutive case series.
To describe retinal manifestations seen in patients associated with COVID-19 infection at a multi-specialty tertiary care hospital in Southern India.
In this retrospective chart review, all consecutive cases presenting to the Re... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-SA | 33913876 | 19,548,883 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Autoimmune haemolytic anaemia'. | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE, THIOTEPA, THYMOCYTE IMMUNE GLOBULIN NOS, TREOSULFAN | DrugsGivenReaction | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | CORTICOSTEROID NOS, CYCLOSPORINE, ELTROMBOPAG, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, SIROLIMUS | DrugsGivenReaction | CC BY | 33914175 | 19,726,321 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemolysis'. | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | CYCLOSPORINE, DARATUMUMAB, ECULIZUMAB, HUMAN IMMUNOGLOBULIN G, METHYLPREDNISOLONE, PREDNISOLONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33914175 | 19,235,954 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune thrombocytopenia'. | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE, THIOTEPA, THYMOCYTE IMMUNE GLOBULIN NOS, TREOSULFAN | DrugsGivenReaction | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mucosal inflammation'. | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | CYCLOSPORINE, FLUDARABINE PHOSPHATE, METHOTREXATE, THIOTEPA, THYMOCYTE IMMUNE GLOBULIN NOS, TREOSULFAN | DrugsGivenReaction | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'No adverse event'. | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | CORTICOSTEROID NOS, CYCLOSPORINE, ELTROMBOPAG, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, SIROLIMUS | DrugsGivenReaction | CC BY | 33914175 | 19,726,321 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | CORTICOSTEROID NOS, CYCLOSPORINE, ELTROMBOPAG, HUMAN IMMUNOGLOBULIN G, RITUXIMAB, SIROLIMUS | DrugsGivenReaction | CC BY | 33914175 | 19,726,321 | 2021-04-29 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33914175 | 19,235,954 | 2021-04-29 |
What was the dosage of drug 'CORTICOSTEROID NOS'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 2 MG/KG, ONCE A DAY | DrugDosageText | CC BY | 33914175 | 19,726,321 | 2021-04-29 |
What was the dosage of drug 'CYCLOSPORINE'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | TROUGH LEVEL 150 ? 200 NG/ML | DrugDosageText | CC BY | 33914175 | 19,726,321 | 2021-04-29 |
What was the dosage of drug 'DARATUMUMAB'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 16 MG/KG/DOSE | DrugDosageText | CC BY | 33914175 | 19,235,954 | 2021-04-29 |
What was the dosage of drug 'ECULIZUMAB'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 25 MG/KG | DrugDosageText | CC BY | 33914175 | 19,235,954 | 2021-04-29 |
What was the dosage of drug 'ELTROMBOPAG'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 50 TO 75 MG DAILY | DrugDosageText | CC BY | 33914175 | 19,726,321 | 2021-04-29 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 4X40 MG/M2 | DrugDosageText | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
What was the dosage of drug 'METHYLPREDNISOLONE'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | PULSES 20 MG/KG/DAY FOR 3 DAYS | DrugDosageText | CC BY | 33914175 | 19,235,954 | 2021-04-29 |
What was the dosage of drug 'SIROLIMUS'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | TROUGH LEVELS 8 ? 12 NG/ML | DrugDosageText | CC BY | 33914175 | 19,726,321 | 2021-04-29 |
What was the dosage of drug 'THIOTEPA'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 1X8 MG/KG | DrugDosageText | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
What was the dosage of drug 'THYMOCYTE IMMUNE GLOBULIN NOS'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 3X15 MG/KG | DrugDosageText | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
What was the dosage of drug 'TREOSULFAN'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | 3X14 G/M2 | DrugDosageText | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
What was the outcome of reaction 'Autoimmune haemolytic anaemia'? | Daratumumab therapy for post-HSCT immune-mediated cytopenia: experiences from two pediatric cases and review of literature.
BACKGROUND
Immune-mediated cytopenias (AIC) are challenging complications following allogeneic hematopoietic stem cell transplantation (HSCT). While broad-acting immunosuppressive agents like cort... | Fatal | ReactionOutcome | CC BY | 33914175 | 20,063,501 | 2021-04-29 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute myocardial infarction'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arrhythmia'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac death'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiotoxicity'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chest pain'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal toxicity'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematotoxicity'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypertension'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Nephropathy toxic'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Plasma cell myeloma'. | Multiple Myeloma Patients Undergoing Carfilzomib: Development and Validation of a Risk Score for Cardiovascular Adverse Events Prediction.
Cardiovascular adverse events (CVAEs) are linked to Carfilzomib (CFZ) therapy in multiple myeloma (MM); however, no validated protocols on cardiovascular risk assessment are availab... | CARFILZOMIB | DrugsGivenReaction | CC BY | 33915804 | 19,122,247 | 2021-04-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.